http:// Approx. 20 Min
Aug. 12, 2022
Alarmingly High Rates of Teen Myocarditis in Thailand: 1 in 43
- Study looked at 301 teens between ages 13-18 & studied their hearts before “vaccination” and after “vaccination”: preprints202208.0151.v1
- Three teens in the group developed myocarditis or pericarditis
- Four more developed sub-clinical myocarditis (which means children are sustaining heart damage but don’t know it)
- Heart damage causes scarring which sets-up abnormal heart rhythms which can lead to cardiac arrests
- Two were hospitalized for 4-5 days
- 29% had cardiovascular symptoms (palpitations, chest pain, etc)
- No institution in the U.S. has studied this
- We have been relying upon spontaneous reporting which is likely grossly underreported
- The reason myocarditis in children is so important is because a study from Brazil showed that adrenaline & noradrenaline from exercise can trigger cardiac arrest, and may explain why scores of athletes are dying on the playing field after the injections.
- COVID injections for children are not medically necessary, are not clinically indicated, randomized trials show no clinical benefit, efficacy is far below 50%, there’s no differential in important clinical outcomes, and they don’t reduce spread.
- It is diabolical that some are using children as human shields to protect adults when this has never been proven scientifically
- Denmark has it right and all COVID shots for young people should be withdrawn
- Young people dying in their sleep is now a regular occurrence
- More children have died from the mRNA shots than from COVID
Abstract: This study focuses on cardiovascular effects, particularly myocarditis and pericarditis events, after BNT162b2 mRNA COVID-19 vaccine injection in Thai adolescents. This prospective cohort study enrolled students from two schools aged 13–18 years who received the second dose of the BNT162b2 mRNA COVID-19 vaccine. Data including demographics, symptoms, vital signs, ECG, echocardiography and cardiac enzymes were collected at baseline, Day 3, Day 7, and Day 14 (optional) using case record forms. We enrolled 314 participants; of these, 13 participants were lost to followup, leaving 301 participants for analysis. The most common cardiovascular effects were:
- tachycardia (7.64%)
- shortness of breath (6.64%)
- palpitation (4.32%)
- chest pain (4.32%)
- hypertension (3.99%)
Seven participants (2.33%) exhibited at least one elevated cardiac biomarker or positive lab assessments. Cardiovascular effects were found in 29.24% of patients, ranging from tachycardia, palpitation, and myopericarditis. Myopericarditis was confirmed in one patient after vaccination. Two patients had suspected pericarditis and four patients had suspected subclinical myocarditis.
Conclusion: Cardiovascular effects in adolescents after BNT162b2 mRNA COVID-19 vaccination included tachycardia, palpitation, and myocarditis. The clinical presentation of myopericarditis after vaccination was usually mild, with all cases fully recovering within 14 days. Hence, adolescents receiving mRNA vaccines should be monitored for side effects.